Semagludite for 3 dollars

Articles like this remind me of how f’d up somethings can be in the US. Our patent laws allow big companies to extend and extend their patents through various means and Americans keep paying and paying…. And even when a medication’s patent expires, collusion and corporate greed maintain artificially high prices.

For example, Liraglutide’s patent expired in 2024, cheap in India, but still several hundred dollars per month here…. Generic pharmaceutical grade sema will never be truly “cheap” here, ever.
 
Big pharma will continue to create patent thickets involving various aspects of these products in order to evergreen their stranglehold on the market and the milk every dollar out of the public.

And legislative support for the crackdown on peptides is probably due to lobbying by Big Pharma.
 
Articles like this remind me of how f’d up somethings can be in the US. Our patent laws allow big companies to extend and extend their patents through various means and Americans keep paying and paying…. And even when a medication’s patent expires, collusion and corporate greed maintain artificially high prices.

For example, Liraglutide’s patent expired in 2024, cheap in India, but still several hundred dollars per month here…. Generic pharmaceutical grade sema will never be truly “cheap” here, ever.
Big Pharma's weight-loss game is straight-up Las Vegas on steroids, those massive, glittering casinos didn't get built because gamblers walked out winners every night. Nah, the house always wins in the long run, and the flashing lights just keep the suckers... er, patients... coming back for more.
Las Vegas Win GIF by Feliks Tomasz Konczakowski
 
Big Pharma's weight-loss game is straight-up Las Vegas on steroids, those massive, glittering casinos didn't get built because gamblers walked out winners every night. Nah, the house always wins in the long run, and the flashing lights just keep the suckers... er, patients... coming back for more.

At least a casino doesn't pretend to be looking out for your health 🤣.
 
Weird that this article states $200/month for semaglutide in the US. I'm pretty sure that (regardless of payer) it's still >$1K/month, disregarding short-term startup discounts.
 
Agreed.

I get it they invest billions of dollars in research, some of which never make it out of the lab or never make it to patients. But, really...
I'll just leave this here... Yes that is billion.

Eli Lilly reported a very strong full-year 2025, with revenue of $65.2 billion (a 45% increase from 2024) and a net profit of $20.6 billion. Growth was primarily driven by high demand for diabetes and obesity drugs, specifically Mounjaro and Zepbound, which together brought in $36.5 billion
 
Weird that this article states $200/month for semaglutide in the US. I'm pretty sure that (regardless of payer) it's still >$1K/month, disregarding short-term startup discounts.
You didn't read the fine print.

It read: Monthly cost of semaglutide in the US is stated in 1901 dollars.
 

Trending Topics

Forum Statistics

Threads
18,462
Posts
192,179
Members
61,754
Newest
F1ndZ
Back
Top Bottom